Format

Send to

Choose Destination
J Thorac Oncol. 2018 May;13(5):595-597. doi: 10.1016/j.jtho.2018.03.007.

Anticipating the Next Step in the Management of ALK-Positive NSCLC.

Author information

1
BC Cancer, Vancouver, British Columbia, Canada. Electronic address: cho@bccancer.bc.ca.
PMID:
29703534
DOI:
10.1016/j.jtho.2018.03.007

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center